Oxford Cannabinoid Technologies Holdings Plc

LSE:OCTP Stock Report

Market Cap: UK£3.8m

Oxford Cannabinoid Technologies Holdings Valuation

Is OCTP undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

2/6

Valuation Score 2/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Book vs Peers

  • Price-To-Book vs Industry

  • Price-To-Book vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of OCTP when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: Insufficient data to calculate OCTP's fair value for valuation analysis.

Significantly Below Fair Value: Insufficient data to calculate OCTP's fair value for valuation analysis.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for OCTP?

Other financial metrics that can be useful for relative valuation.

OCTP key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenuen/a
Enterprise Value/EBITDA-0.5x
PEG Ration/a

Price to Book Ratio vs Peers

How does OCTP's PB Ratio compare to its peers?

The above table shows the PB ratio for OCTP vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PBEstimated GrowthMarket Cap
Peer Average2.3x
N4P N4 Pharma
1.9xn/aUK£2.2m
IMM ImmuPharma
4.9xn/aUK£8.5m
ANA Ananda Developments
1.9xn/aUK£9.1m
NFX Nuformix
0.4xn/aUK£1.5m
OCTP Oxford Cannabinoid Technologies Holdings
2x15.1%UK£3.8m

Price-To-Book vs Peers: OCTP is good value based on its Price-To-Book Ratio (2x) compared to the peer average (2.3x).

Price to Earnings Ratio vs Industry

How does OCTP's PE Ratio compare vs other companies in the GB Pharmaceuticals Industry?

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
Industry Avg.n/a15.4%
 n/an/an/a
No. of CompaniesPB048121620

Fetching data

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
Industry Avg.n/a15.4%
 n/an/an/a
No more companies

Price-To-Book vs Industry: OCTP is good value based on its Price-To-Book Ratio (2x) compared to the UK Pharmaceuticals industry average (3.4x).

Price to Book Ratio vs Fair Ratio

What is OCTP's PB Ratio compared to its Fair PB Ratio? This is the expected PB Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

OCTP PB Ratio vs Fair Ratio.
Fair Ratio
Current PB Ratio2x
Fair PB Ration/a

Price-To-Book vs Fair Ratio: Insufficient data to calculate OCTP's Price-To-Book Fair Ratio for valuation analysis.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.

Discover undervalued companies

7D

1Y

7D

1Y

7D

1Y

Simply Wall St™
Simply Wall Street Pty Ltd
Level 7, 320 Pitt Street, Sydney
Download on the App StoreGet it on Google Play
Popular Markets
USAUUKINCAZA
About UsCareersPlansLogin
Help CenterLatest CoveragePodcastsAffiliate ProgramBusiness & Enterprise
Financial Services GuideTerms and ConditionsPrivacy PolicyLogos provided by Clearbit
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.